{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T20:30:01Z","timestamp":1768249801044,"version":"3.49.0"},"reference-count":146,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.critrevonc.2012.10.001","type":"journal-article","created":{"date-parts":[[2012,11,11]],"date-time":"2012-11-11T02:15:23Z","timestamp":1352600123000},"page":"69-84","source":"Crossref","is-referenced-by-count":43,"title":["Mechanisms, indications and results of salvage systemic therapy for sporadic and von Hippel\u2013Lindau related hemangioblastomas of the central nervous system"],"prefix":"10.1016","volume":"86","author":[{"given":"Jody Filippo","family":"Capitanio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Mazza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micaela","family":"Motta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Mortini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Reni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2012.10.001_bib0005","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1212\/WNL.41.1.41","article-title":"Central nervous system involvement in von Hippel\u2013Lindau disease","volume":"41","author":"Filling-Katz","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0010","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0025-6196(11)65031-3","article-title":"von Hippel\u2013Lindau disease","volume":"75","author":"Couch","year":"2000","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0015","first-page":"505","article-title":"von Hippel\u2013Lindau disease: protocols for diagnosis and periodical clinical monitoring National von Hippel\u2013Lindau Disease Working Group","volume":"144","author":"Hes","year":"2000","journal-title":"Nederlands Tijdschrift Voor Geneeskunde"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0020","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3171\/jns.2003.98.1.0082","article-title":"The natural history of hemangioblastomas of the central nervous system in patients with von Hippel\u2013Lindau disease","volume":"98","author":"Wanebo","year":"2003","journal-title":"Journal of Neurosurgery"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0025","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00005792-199711000-00001","article-title":"von Hippel\u2013Lindau disease","volume":"76","author":"Maher","year":"1997","journal-title":"Medicine"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0030","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1046\/j.1365-2796.1998.00337.x","article-title":"Hemangioblastoma of the central nervous system in von Hippel\u2013Lindau disease","volume":"243","author":"Richard","year":"1998","journal-title":"Journal of Internal Medicine"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0035","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3171\/jns.1989.70.1.0024","article-title":"Hemangioblastomas of the central nervous system. A 10-year study with special reference to von Hippel\u2013Lindau syndrome","volume":"70","author":"Neumann","year":"1989","journal-title":"Journal of Neurosurgery"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0040","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/jmg.33.2.120","article-title":"A genetic register for von Hippel\u2013Lindau disease","volume":"33","author":"Maddock","year":"1996","journal-title":"Journal of Medical Genetics"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0045","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/0959-8049(94)00391-H","article-title":"von Hippel\u2013Lindau disease","volume":"30A","author":"Maher","year":"1994","journal-title":"European Journal of Cancer"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0050","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/S0046-8177(88)80089-3","article-title":"Renal pathology in von Hippel\u2013Lindan disease","volume":"19","author":"Solomon","year":"1996","journal-title":"Human Pathology"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0055","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/S0022-5347(17)53194-8","article-title":"Cysts containing renal cell carcinoma in von Hippel\u2013Lindau disease","volume":"128","author":"Christenson","year":"1982","journal-title":"Journal of Urology"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0060","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/0002-9343(87)90062-3","article-title":"Renal cell carcinoma in VHL syndrome","volume":"82","author":"Malek","year":"1987","journal-title":"American Journal of Medicine"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0065","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/1097-0142(19890101)63:1<148::AID-CNCR2820630124>3.0.CO;2-F","article-title":"Atypical cysts and carcinoma of the kidneys in the phacomatoses","volume":"63","author":"Ibrahim","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0070","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/00005392-199501000-00009","article-title":"Characterization of the renal pathology of a familial form of renal cell carcinoma associated with von Hippel\u2013Lindau disease: clinical and molecular genetic implications","volume":"153","author":"Poston","year":"1995","journal-title":"Journal of Urology"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0075","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.2214\/ajr.162.5.8165988","article-title":"Pancreatic lesions in von Hippel\u2013Lindau disease: prevalence, clinical significance, and CT findings","volume":"162","author":"Hough","year":"1994","journal-title":"American Journal of Roentgenology"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0080","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/eye.1992.18","article-title":"Choroid plexus papilloma. A new presentation of VHL disease","volume":"6","author":"Blamires","year":"1992","journal-title":"Eye"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0085","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1055\/s-2008-1063578","article-title":"Das v. Hippel-Lindau-Syndrom (The von Hippel\u2013Lindau syndrome)","volume":"116","author":"Neumann","year":"1991","journal-title":"Deutsche Medizinische Wochenschrift"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0090","first-page":"4845","article-title":"Somatic mutations of the VHL tumor suppressor gene in sporadic central nervous system hemangioblastomas","volume":"54","author":"Kanno","year":"1994","journal-title":"Cancer Research"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0095","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.8493574","article-title":"Identification of the von Hippel\u2013Lindau disease tumor suppressor gene","volume":"260","author":"Latif","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0100","first-page":"504","article-title":"Loss of heterozygosity and somatic mutation of the VHL suppressor gene in sporadic cerebellar hemangioblastomas","volume":"58","author":"Lee","year":"1998","journal-title":"Cancer Research"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0105","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0046-8177(97)90075-7","article-title":"von Hippel\u2013Lindau gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with von Hippel\u2013Lindau disease","volume":"28","author":"Vortmeyer","year":"1997","journal-title":"Human Pathology"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0110","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0002-9343(64)90107-X","article-title":"Lindau's disease: review of literature and study of a large kindred","volume":"36","author":"Melmon","year":"1964","journal-title":"American Journal of Medicine"},{"issue":"August (2)","key":"10.1016\/j.critrevonc.2012.10.001_bib0115","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1399-0004.2007.00827.x","article-title":"Frequency of von Hippel\u2013Lindau germline mutations in classic and non-classic von Hippel\u2013Lindau disease identified by DNA sequencing, Southern blot analysis and multiplex ligation-dependent probe amplification","volume":"72","author":"Hes","year":"2007","journal-title":"Clinical Genetics"},{"issue":"November\u2013December (6)","key":"10.1016\/j.critrevonc.2012.10.001_bib0120","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1111\/j.1582-4934.2007.00122.x","article-title":"Mosaicism in von Hippel\u2013Lindau disease: an event important to recognize","volume":"11","author":"Santarpia","year":"2007","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0125","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/humu.1380050109","article-title":"Germline mutations in the von Hippel\u2013Lindau disease tumor suppressor gene: correlations with phenotype","volume":"5","author":"Chen","year":"1995","journal-title":"Human Mutation"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0130","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/(SICI)1098-1004(1999)13:6<464::AID-HUMU6>3.0.CO;2-A","article-title":"Mutations of the VHL gene in sporadic renal cell carcinoma: definition of a risk factor for VHL patients to develop an RCC","volume":"13","author":"Gallou","year":"1999","journal-title":"Human Mutation"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0135","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1046\/j.1365-2796.1998.00336.x","article-title":"Genotype\u2013phenotype correlations in von Hippel\u2013Lindau disease","volume":"243","author":"Neumann","year":"1998","journal-title":"Journal of Internal Medicine"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0140","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.beem.2010.01.002","volume":"24","author":"Barontini","year":"2010","journal-title":"Best Practice and Research Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0145","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10143-008-0166-0","article-title":"Solid haemangioblastomas of the CNS: a review of 17 consecutive cases","volume":"32","author":"Rachinger","year":"2009","journal-title":"Neurosurgical Review"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0150","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1023\/B:NEON.0000014493.88402.dc","article-title":"Stabilization of a progressive hemangioblastoma under treatment with thalidomide","volume":"66","author":"Piribauer","year":"2004","journal-title":"Journal of Neuro-Oncology"},{"issue":"1","key":"10.1016\/j.critrevonc.2012.10.001_bib0155","first-page":"41","article-title":"Immunohistochemical and ultrastructural studies of stromal cells in hemangioblastoma","volume":"33","author":"Omulecka","year":"1995","journal-title":"Folia Neuropathologica"},{"issue":"9374","key":"10.1016\/j.critrevonc.2012.10.001_bib0160","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(03)13643-4","article-title":"von Hippel\u2013Lindau disease","volume":"361","author":"Lonser","year":"2003","journal-title":"Lancet"},{"issue":"5229","key":"10.1016\/j.critrevonc.2012.10.001_bib0165","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1126\/science.7660122","article-title":"Inhibition of transcription elongation by the VHL tumor suppressor protein","volume":"269","author":"Duan","year":"1995","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.critrevonc.2012.10.001_bib0170","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrc885","article-title":"Molecular basis of the VHL hereditary cancer syndrome","volume":"2","author":"Kaelin","year":"1995","journal-title":"Nature Reviews Cancer"},{"issue":"6733","key":"10.1016\/j.critrevonc.2012.10.001_bib0175","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/20459","article-title":"The tumour suppressor protein VHL targets hypoxia inducible factors for oxygen-dependent proteolysis","volume":"399","author":"Maxwell","year":"1999","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.critrevonc.2012.10.001_bib0180","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1073\/pnas.94.6.2156","article-title":"The von Hippel\u2013Lindau tumor-suppressor gene product forms a stable complex with human CUL2, a member of the Cdc53 family of proteins","volume":"94","author":"Pause","year":"1997","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0185","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1146\/annurev.cellbio.15.1.551","article-title":"Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1","volume":"15","author":"Semenza","year":"1999","journal-title":"Annual Review of Cell and Developmental Biology"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0190","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(00)81957-1","article-title":"Perspectives on oxygen sensing","volume":"98","author":"Semenza","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0195","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1242\/jeb.203.8.1253","article-title":"Mammalian oxygen sensing, signaling and gene regulation","volume":"203","author":"Wenger","year":"2000","journal-title":"Journal of Experimental Biology"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0200","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0034-5687(99)00024-9","article-title":"Oxygen sensing and signaling: impact on the regulation of physiologically important genes","volume":"115","author":"Zhu","year":"1999","journal-title":"Respiration Physiology"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000075346","article-title":"von Hippel\u2013Lindau Tumor Suppressor Protein and Hypoxia-Inducible Factor in Kidney Cancer","volume":"24","author":"Maynard","year":"2004","journal-title":"American Journal of Nephrology"},{"issue":"6692","key":"10.1016\/j.critrevonc.2012.10.001_bib0210","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/28867","article-title":"Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis","volume":"394","author":"Carmeliet","year":"1998","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.critrevonc.2012.10.001_bib0215","first-page":"245","article-title":"Coexpression of transforming growth factor-alpha and epidermal growth factor receptor in capillary hemangioblastomas of the central nervous system","volume":"147","author":"Reifenberger","year":"1995","journal-title":"American Journal of Pathology"},{"issue":"2","key":"10.1016\/j.critrevonc.2012.10.001_bib0220","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1371\/journal.pmed.0040060","article-title":"von Hippel\u2013Lindau disease-associated hemangioblastomas are derived from embryologic multipotent cells","volume":"4","author":"Park","year":"2007","journal-title":"PLoS Medicine"},{"issue":"August (2)","key":"10.1016\/j.critrevonc.2012.10.001_bib0225","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3171\/jns.2006.105.2.248","article-title":"Long-term natural history of hemangioblastomas in patients with von Hippel\u2013Lindau disease: implications for treatment","volume":"105","author":"Ammerman","year":"2006","journal-title":"Journal of Neurosurgery"},{"issue":"11","key":"10.1016\/j.critrevonc.2012.10.001_bib0230","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1001\/jama.300.11.1334","article-title":"Neurologic manifestations of von Hippel\u2013Lindau disease","volume":"300","author":"Butman","year":"2008","journal-title":"The Journal of the American Medical Association"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0235","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1002\/(SICI)1097-0142(19991201)86:11+<2478::AID-CNCR4>3.0.CO;2-5","article-title":"von Hippel\u2013Lindau syndrome","volume":"86","author":"Friedrich","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0240","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1227\/00006123-198303000-00015","article-title":"Supratentorial capillary hemangioblastoma presenting with fatal spontaneous intracerebral hemorrhage","volume":"12","author":"Adegbite","year":"1983","journal-title":"Neurosurgery"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0245","doi-asserted-by":"crossref","first-page":"937","DOI":"10.3171\/jns.1994.81.6.0937","article-title":"Intramedullary hemorrhage in spinal cord hemangioblastoma. Report of two cases","volume":"81","author":"Yu","year":"1994","journal-title":"Journal of Neurosurgery"},{"issue":"July (1)","key":"10.1016\/j.critrevonc.2012.10.001_bib0250","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1227\/01.NEU.0000163250.71951.18","article-title":"Risk of hemorrhage in hemangioblastomas of the central nervous system","volume":"57","author":"Gl\u00e4sker","year":"2005","journal-title":"Neurosurgery"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0255","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10143-009-0217-1","volume":"33","author":"Ros de San Pedro","year":"2010","journal-title":"Neurosurgical Review"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0260","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1227\/00006123-199012000-00022","article-title":"Spinal cord hemangioblastoma with subarachnoid haemorrhage","volume":"27","author":"Cerejo","year":"1990","journal-title":"Neurosurgery"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0265","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1227\/00006123-198006000-00009","article-title":"Subarachnoid haemorrhage due to a spinal cord hemangioblastoma: case report","volume":"6","author":"Kormos","year":"1980","journal-title":"Neurosurgery"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0270","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1148\/radiology.194.3.7862955","article-title":"von Hippel Lindau disease: genetic, clinical and imaging features","volume":"194","author":"Choyke","year":"1995","journal-title":"Radiology"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0275","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/0002-9343(61)90120-6","article-title":"The association of polycythemia with a cerebellar hemangioblastoma. The production of an erythropoiesis stimulating factor by the tumour","volume":"31","author":"Waldmann","year":"1961","journal-title":"American Journal of Medicine"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0280","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1227\/00006123-199107000-00006","article-title":"Extramedullary hematopoiesis in cerebellar HBs","volume":"29","author":"Zec","year":"1991","journal-title":"Neurosurgery"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0285","first-page":"321","article-title":"Surgical management of isolated HBs of the spinal cord","volume":"49","author":"Roonprapunt","year":"2001","journal-title":"Neurosurgery"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0295","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1227\/00006123-199309000-00022","article-title":"Preoperative embolization of brain and spinal hemangioblastomas","volume":"33","author":"Tampieri","year":"1993","journal-title":"Neurosurgery"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0300","first-page":"525","article-title":"Preoperative endovascular embolization of craniospinal hemangioblastomas","volume":"17","author":"Eskridge","year":"1996","journal-title":"American Journal of Neuroradiology"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0305","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3171\/2009.5.JNS08442","article-title":"Fluorescence diagnosis of tumor cells in hemangioblastoma cysts with 5-aminolevulinic acid","volume":"112","author":"Satoshi","year":"2010","journal-title":"Journal of Neurosurgery"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0310","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s007010070107","article-title":"Stereotactic radiosurgery for hemangioblastomas of the brain","volume":"142","author":"Jawahar","year":"2000","journal-title":"Acta Neurochirurgica"},{"issue":"May (5)","key":"10.1016\/j.critrevonc.2012.10.001_bib0315","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/0360-3016(90)90454-R","article-title":"Radiotherapeutic considerations in the treatment of hemangioblastomas of the central nervous system","volume":"18","author":"Smalley","year":"1990","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"June (3)","key":"10.1016\/j.critrevonc.2012.10.001_bib0320","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0360-3016(96)80011-3","article-title":"Radiosurgery for hemangioblastoma: results of a multiinstitutional experience","volume":"35","author":"Patrice","year":"1996","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"February (3)","key":"10.1016\/j.critrevonc.2012.10.001_bib0325","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/1097-0142(19820201)49:3<553::AID-CNCR2820490326>3.0.CO;2-A","article-title":"Cerebellar hemangioblastomas","volume":"49","author":"Sung","year":"1982","journal-title":"Cancer"},{"issue":"November (11)","key":"10.1016\/j.critrevonc.2012.10.001_bib0330","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/0360-3016(87)90154-4","article-title":"Adjuvant radiation therapy after surgical resection of solitary brain metastasis: association with pattern of failure and survival","volume":"13","author":"Smalley","year":"1987","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0335","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00006123-199807000-00018","article-title":"Treatment of hemangioblastomas in von Hippel\u2013Lindau disease with linear accelerator-based radiosurgery","volume":"43","author":"Chang","year":"1998","journal-title":"Neurosurgery"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0340","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s00701-007-1274-2","article-title":"Gamma knife radiosurgery for intracranial haemangioblastomas","volume":"149","author":"Matsunaga","year":"2007","journal-title":"Acta Neurochirurgica"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0345","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3171\/jns.1996.85.4.0591","article-title":"Gamma knife radiosurgery in 11 hemangioblastomas","volume":"85","author":"Niemela","year":"1996","journal-title":"Journal of Neurosurgery"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0350","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1227\/01.NEU.0000348015.51685.D2","article-title":"Stereotactic radiosurgical treatment of cranial and spinal hemangioblastomas","volume":"65","author":"Moss","year":"2009","journal-title":"Neurosurgery"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0355","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3171\/jns.2005.102.s_supplement.0097","article-title":"Gamma knife surgery for multiple hemangioblastomas","volume":"102","author":"Park","year":"2005","journal-title":"Journal of Neurosurgery"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0360","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3171\/jns.2005.102.s_supplement.0171","article-title":"Gamma knife surgery for hemangioblastomas","volume":"102","author":"Tago","year":"2005","journal-title":"Journal of Neurosurgery"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0365","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3171\/jns.2005.102.s_supplement.0225","article-title":"The long-term results of gamma knife radiosurgery for hemangioblastomas of the brain","volume":"102","author":"Wang","year":"2005","journal-title":"Journal of Neurosurgery"},{"issue":"1","key":"10.1016\/j.critrevonc.2012.10.001_bib0370","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.wneu.2010.09.032","article-title":"Gamma knife radiosurgery for intracranial hemangioblastomas \u2013 outcome at 3 years","volume":"75","author":"Sayer","year":"2011","journal-title":"World Neurosurgery"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0375","first-page":"3310","article-title":"The phakomatoses","volume":"vol. 5","author":"Ebert","year":"1974"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0380","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0002-9394(76)90418-9","article-title":"Light and electron microscopic study of early lesions in angiomatosis retinae","volume":"82","author":"Nicholson","year":"1976","journal-title":"American Journal of Ophthalmology"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0385","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1001\/archopht.1974.01010010132010","article-title":"Argon laser treatment of von Hippel Lindau retinal angiomas. II: histopathology of treated lesions","volume":"92","author":"Apple","year":"1974","journal-title":"Archives of Ophthalmology"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0390","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000338230","article-title":"Primitive retinal vascular abnormalities: tumors and telangiectasias","volume":"228","author":"Knutsson","year":"2012","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0395","first-page":"3067","article-title":"Retinal hemangioblastoma in von Hippel Lindau disease: a clinical and molecular study","volume":"43","author":"Dollfus","year":"2002","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"December (6)","key":"10.1016\/j.critrevonc.2012.10.001_bib0400","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1365-2990.2005.00669.x","article-title":"Cellular and reticular variants of haemangioblastoma revisited: a clinicopathologic study of 88 cases","volume":"31","author":"Hasselblatt","year":"2005","journal-title":"Neuropathology and Applied Neurobiology"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0405","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0002-9440(10)65541-1","article-title":"Up-regulation of vascular endothelial growth factor in stromal cells of hemangioblastomas is correlated with up-regulation of the transcription factor HRF\/HIF-2alfa","volume":"153","author":"Flamme","year":"1998","journal-title":"American Journal of Pathology"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0410","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00002371-199903000-00006","article-title":"Regimens with or without interferon-\u03b1 as treatment for metastatic melanoma and renal cell carcinoma: an overview of randomized trials","volume":"22","author":"Hernberg","year":"1999","journal-title":"Journal of Immunotherapy"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0415","first-page":"5155","article-title":"Inhibition of angiogenesis by interferons: effects on tumor and lymphocyte-induced vascular responses","volume":"47","author":"Sidky","year":"1987","journal-title":"Cancer Research"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0420","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3109\/10428199409056295","article-title":"Hairy cell leukemia: a clinical review based on 725 cases of the Italian cooperative group (ICGHCL)","volume":"13","author":"Frassoldati","year":"1994","journal-title":"Leukemia and Lymphoma"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0425","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199205283262203","article-title":"Interferon alfa-2a therapy for life-threatening hemangiomas of infancy","volume":"326","author":"Ezekowitz","year":"1992","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0430","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1126\/science.6154315","article-title":"Inhibition of cell motility by interferon","volume":"208","author":"Brouty-Boye","year":"1980","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0435","first-page":"5155","article-title":"Inhibition of angiogenesis by interferons: effects on tumor- and lymphocyte-induced vascular responses","volume":"47","author":"Sidky","year":"1987","journal-title":"Cancer Research"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0440","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/jnci\/81.7.497","article-title":"Microvascular injury in pathogenesis of interferon-induced necrosis of subcutaneous tumors in mice","volume":"81","author":"Dvorak","year":"1989","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0445","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/jnci\/95.6.437","article-title":"Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis","volume":"95","author":"von Marschall","year":"2003","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0450","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1056\/NEJM198905043201807","article-title":"Treatment of pulmonary hemangiomatosis with recombinant interferon alfa-2a","volume":"320","author":"White","year":"1989","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0455","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1056\/NEJM198905043201811","article-title":"Successful treatment of an angiogenic disease","volume":"320","author":"Folkman","year":"1989","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0460","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.1073\/pnas.92.10.4562","article-title":"Interferons alpha and beta down-regulate the expression of basic fibroblast growth factor in human carcinomas","volume":"92","author":"Singh","year":"1995","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0465","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/sj.neo.7900128","article-title":"Suppression of angiogenesis and therapy of human colon cancer liver metastasis by systemic administration of interferon-alpha","volume":"3","author":"Ozawa","year":"2001","journal-title":"Neoplasia"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0470","first-page":"510","article-title":"Interferon \u03b1-2a therapy in 18 hemangioblastomas","volume":"7","author":"Niemela","year":"2001","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0475","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1200\/JCO.1996.14.1.7","article-title":"Interferon a-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684","volume":"14","author":"Kirkwood","year":"1996","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0480","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1200\/JCO.1999.17.9.2859","article-title":"Prospective randomized trial of interferon \u03b1-2a plus vinblastine versus vinblastine alone in patients with advanced renal cell cancer","volume":"17","author":"Pyrhonen","year":"1999","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0485","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0092-8674(93)90573-9","article-title":"High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis","volume":"72","author":"Millauer","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0490","doi-asserted-by":"crossref","first-page":"7533","DOI":"10.1073\/pnas.90.16.7533","article-title":"Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium","volume":"90","author":"Quinn","year":"1993","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0495","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1002\/j.1460-2075.1994.tb06631.x","article-title":"Targeted expression of a dominant negative FGF receptor blocks branching morphogenesis and epithelial differentiation of the mouse lung","volume":"13","author":"Peters","year":"1994","journal-title":"EMBO Journal"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0500","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/367576a0","article-title":"Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant","volume":"367","author":"Millauer","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0505","first-page":"1615","article-title":"Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo","volume":"56","author":"Millauer","year":"1996","journal-title":"Cancer Research"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0510","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/380439a0","article-title":"Heterozygous embryonic lethality induced by targeted inactivation of VEGF gene","volume":"380","author":"Ferrara","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0515","first-page":"393","article-title":"Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence","volume":"56","author":"Saleh","year":"1996","journal-title":"Cancer Research"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0520","first-page":"172","article-title":"Expression of vascular permeability factor\/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis","volume":"56","author":"Claffey","year":"1996","journal-title":"Cancer Research"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0525","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/362841a0","article-title":"Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo","volume":"362","author":"Kim","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0530","first-page":"5296","article-title":"Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor\/vascular permeability factor 121","volume":"55","author":"Asano","year":"1995","journal-title":"Cancer Research"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0535","first-page":"91","article-title":"In vitro neutralization of vascular endothelial growth factor activation of Flk-1 by a monoclonal antibody","volume":"3","author":"Rockwell","year":"1995","journal-title":"Molecular and Cellular Differentiation"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0540","first-page":"266","article-title":"Antitumor activity of anti-Flk-1 monoclonal antibodies","volume":"38","author":"Rockwell","year":"1997","journal-title":"Proceedings of the American Association of Cancer Research"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0545","series-title":"Angiogenesis inhibitors and other novel therapeutic strategies for ocular diseases of neovascularization","article-title":"Ribozyme inhibition of VEGF-mediated endothelial cell proliferation in cell culture and VEGF-induced angiogenesis in a rat corneal model","author":"Cushman","year":"1996"},{"issue":"January (1)","key":"10.1016\/j.critrevonc.2012.10.001_bib0550","first-page":"99","article-title":"SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1\/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types","volume":"59","author":"Fong","year":"1999","journal-title":"Cancer Research"},{"issue":"8","key":"10.1016\/j.critrevonc.2012.10.001_bib0555","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jama.291.8.943","article-title":"Antiangiogenic therapy for von Hippel\u2013Lindau disease","volume":"291","author":"Madhusudan","year":"2004","journal-title":"The Journal of the American Medical Association"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0560","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","article-title":"Reporting results of cancer treatment","volume":"47","author":"Miller","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0565","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1182\/blood.V99.10.3851","article-title":"Paradoxical secondary polycythemia in von Hippel\u2013Lindau patients treated with antivascular endothelial growth factor receptor therapy","volume":"99","author":"Richard","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2012.10.001_sbref0570a","first-page":"685","article-title":"A phase I trial of the VEGF inhibitor SU5416, incorporating dynamic contrast MRI assessment of vascular permeability","volume":"19","author":"O\u2019Donnell","year":"2000","journal-title":"Proceedings of the ASCO"},{"key":"10.1016\/j.critrevonc.2012.10.001_sbref0570b","first-page":"802","volume":"19","author":"Stopeck","year":"2000","journal-title":"Proceedings of the ASCO"},{"key":"10.1016\/j.critrevonc.2012.10.001_sbref0570c","first-page":"683","volume":"19","author":"Miles","year":"2000","journal-title":"Proceedings of the ASCO"},{"key":"10.1016\/j.critrevonc.2012.10.001_sbref0570d","first-page":"2087","volume":"41","author":"Rosen","year":"2000","journal-title":"Proceedings of the AACR"},{"key":"10.1016\/j.critrevonc.2012.10.001_sbref0570e","first-page":"5D","volume":"19","author":"Rosen","year":"2000","journal-title":"Proceedings of the AACR"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0575","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1182\/blood.V97.5.1413","article-title":"The anti-angiogenic protein kinase inhibitors SU5416 and SU6668 inhibit the SCF receptor (c-kit) in a human myeloid leukemia cell line and in acute myeloid leukemia blasts","volume":"97","author":"Smolich","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0580","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/0002-9343(61)90120-6","article-title":"The association of polycythemia with cerebellar hemangioblastoma","volume":"31","author":"Waldmann","year":"1961","journal-title":"American Journal of Medicine"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0585","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1182\/blood.V78.3.599.599","article-title":"Secondary erythrocytosis is due to a cerebellar hemangio-blastoma: demonstration of erythropoietin mRNA in the tumor","volume":"78","author":"Trimble","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0590","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1182\/blood.V92.9.3388","article-title":"Coexpression of erythropoietin and vascular endothelial growth factor in nervous system tumors associated with von Hippel\u2013Lindau tumor suppressor gene loss of function","volume":"92","author":"Krieg","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0595","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0046-8177(97)90075-7","article-title":"von Hippel\u2013Lindau gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with von Hippel\u2013Lindau disease","volume":"28","author":"Vortmeyer","year":"1998","journal-title":"Human Pathology"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0600","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/S0161-6420(02)01159-4","article-title":"Rapid and durable recovery of visual function in a patient with von Hippel\u2013Lindau syndrome after systemic therapy with vascular endothelial growth factor receptor inhibitor su5416","volume":"109","author":"Aiello","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0605","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0002-9394(03)00101-6","article-title":"Treatment of von Hippel\u2013Lindau retinal hemangioblastoma by the vascular endothelial growth factor receptor inhibitor SU5416 is more effective for associated macular edema than for hemangioblastomas","volume":"136","author":"Girmens","year":"2003","journal-title":"American Journal of Ophthalmology"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0610","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1200\/JCO.2005.01.184","article-title":"Case 2. Hemangioblastomas: diagnosis of von Hippel\u2013Lindau disease and antiangiogenic treatment with SU5416","volume":"23","author":"Schuch","year":"2005","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0615","first-page":"2178","article-title":"PTK787\/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration","volume":"60","author":"Wood","year":"2000","journal-title":"Cancer Research"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0620","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2174\/1874364101004010066","article-title":"Long-term use of intravitreal bevacizumab (Avastin) for the treatment of von Hippel\u2013Lindau associated retinal hemangioblastomas","volume":"4","author":"Hrisomalos","year":"2010","journal-title":"The Open Ophthalmology Journal"},{"issue":"June (25)","key":"10.1016\/j.critrevonc.2012.10.001_bib0625","doi-asserted-by":"crossref","first-page":"22382","DOI":"10.1074\/jbc.M100938200","volume":"276","author":"Keifer","year":"2001","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0630","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0167-5699(99)01531-5","volume":"20","author":"Marriott","year":"1999","journal-title":"Immunology Today"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0635","doi-asserted-by":"crossref","first-page":"364","DOI":"10.2165\/00002018-199512060-00002","volume":"12","author":"Schuler","year":"1995","journal-title":"Drug Safety"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0640","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1084\/jem.173.3.699","volume":"173","author":"Sampaio","year":"1991","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0645","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0954-6111(97)90134-7","volume":"91","author":"Tavares","year":"1997","journal-title":"Respiratory Medicine"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0650","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.4049\/jimmunol.159.10.5157","volume":"159","author":"Moller","year":"1997","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0655","doi-asserted-by":"crossref","first-page":"380","DOI":"10.4049\/jimmunol.163.1.380","volume":"163","author":"Corral","year":"1999","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0660","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1073\/pnas.91.9.4082","volume":"91","author":"D\u2019Amato","year":"1994","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0665","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1006\/exer.1997.0292","volume":"64","author":"Kenyon","year":"1997","journal-title":"Experimental Eye Research"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0670","doi-asserted-by":"crossref","first-page":"22382","DOI":"10.1074\/jbc.M100938200","article-title":"Inhibition of NF-kappa B activity by thalidomide through suppression of IkappaB kinase activity","volume":"276","author":"Keifer","year":"2001","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0675","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1084\/jem.173.3.699","article-title":"Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes","volume":"173","author":"Sampaio","year":"1991","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0680","first-page":"2481","article-title":"Thalidomide downregulates the expression of VEGF and bFGF in cisplatin-resistant human lung carcinoma cells","volume":"23","author":"Li","year":"2003","journal-title":"Anticancer Research"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0685","first-page":"3349","article-title":"Thalidomide and its analogues inhibit lipopolysaccharide-mediated induction of cyclooxygenase 2","volume":"7","author":"Fujita","year":"2001","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0690","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1126\/science.281.5383.1680","volume":"281","author":"Wang","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0695","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.1128\/MCB.19.8.5785","volume":"19","author":"Guttridge","year":"1999","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0700","first-page":"M55","volume":"1470","author":"Mayo","year":"2000","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0705","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1200\/JCO.2004.10.127","article-title":"Thalidomide: current role in the treatment of non-plasma cell malignancies","volume":"22","author":"Kumar","year":"2004","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0710","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1023\/B:NEON.0000014493.88402.dc","article-title":"Stabilization of a progressive HB under treatment with thalidomide","volume":"66","author":"Piribauer","year":"2004","journal-title":"Journal of Neuro-Oncology"},{"key":"10.1016\/j.critrevonc.2012.10.001_bib0715","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/pbc.22065","article-title":"Monotherapy with thalidomide for treatment of spinal cord hemangioblastomas in a patient with von Hippel\u2013Lindau disease","volume":"53","author":"Sardi","year":"2009","journal-title":"Pediatr Blood Cancer"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842812002077?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842812002077?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T18:35:46Z","timestamp":1687804546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842812002077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":146,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S1040842812002077"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2012.10.001","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}